Kenya: Kisumu Receives 171,000 Measles, Rubella Vaccine Doses

[Capital FM] Kisumu -- Kisumu County has received 171,000 doses o support an ongoing vaccination campaign against measles and rubella.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news

Related Links:

Vaccine. 2021 Dec 24:S0264-410X(21)01630-3. doi: 10.1016/j.vaccine.2021.12.022. Online ahead of print.ABSTRACTThe COVID-19 pandemic disrupted routine vaccinations for children and adolescents. However, it remains unclear whether the impact has been different for children and adolescents from low-income families. To address this, we compared monthly routine vaccination use per 1000 vaccine-eligible children and adolescents enrolled in Louisiana Medicaid in the years before (2017-2019) and during the COVID-19 pandemic (2020). Compared to the 2017-2019 average vaccination rates, we found a 28% reduction in measles, mumps, and...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
Despite high rate of vaccination coverage with 2-doses of measles containing vaccine among Iranian children, outbreaks of measles occurred among different age groups and fully vaccinated subjects. Although the...
Source: BMC Immunology - Category: Allergy & Immunology Authors: Tags: Research Source Type: research
We describe a measles outbreak among previously vaccinated healthcare workers (HCWs) and inpatients and the control measures implemented at a tertiary care hospital in 2019. Case-patients were laboratory-confirmed measles with throat swabs tested by quantitative polymerase chain reactions (PCR), during April –May 2019. Medical histories and documented immunization records were obtained. We compared attack rates (ARs) among HCWs by occupational subgroup and age and examined the outbreak-associated costs. The index case was not ascertained. Among 26 measles case-patients (22 HCWs, four inpatients) aged 18–28 ...
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research
We reported three cases of immune thrombocytopenia (ITP) that developed within 6 weeks after ChAdOx1 nCoV-19 vaccination. Antiplatelet factor 4 antibodies were undetectable in all three cases. Therefore, vaccine-induced immune thrombotic thrombocytopenia was very unlikely. Other potential causes of thrombocytopenia were excluded. Their clinical presentations, severity of thrombocytopenia and outcomes were varied. Only one ITP case, an 80-year-old man, received ITP treatments and achieved complete response after 2 weeks of eltrombopag. An 84-year-old man had spontaneous complete remission, and a 55-year-old woman had partia...
Source: Blood Coagulation and Fibrinolysis - Category: Hematology Tags: CASE REPORT Source Type: research
In this study we investigate whether the accelerated schedule of MMR2 leads to a change in coverage of MMR2 and other childhood vaccines with an ecological study using childhood immunisation data from 2009 to 2018 in London.METHODS: We modelled coverage used generalized estimating equations (GEE) adjusted for year and DTaP/IPV/Hib3 coverage measured at 2nd birthday as a proxy for baseline local vaccination programme performance to determine the percentage point difference in coverage of MMR2 and other childhood vaccines.RESULTS: Average MMR2 coverage was higher among early implementing boroughs from 2012/13 onwards. Covera...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
Biomed Res Int. 2021 Dec 14;2021:6995096. doi: 10.1155/2021/6995096. eCollection 2021.ABSTRACTAt the beginning of the COVID-19 pandemic, early modelling studies estimated a reduction in childhood vaccinations in low- and middle-income countries. Regular provision of both curative and preventive services such as antenatal care and childhood immunizations has been negatively affected since the onset of the pandemic. Our study was aimed at examining the impact that the pandemic had on childhood vaccination services at the Tamale Teaching Hospital (TTH). A mixed methods study design was employed for the study, which was conduc...
Source: Biomed Res - Category: Research Authors: Source Type: research
Conditions:   Immunotoxicity;   Vaccine Intervention:   Biological: Measles, Mumps and Rubella Combined Vaccine, Live Sponsor:   Shanghai Institute Of Biological Products Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Kenya Health | Measles | Measles Vaccine | Rubella | Rubella Vaccine | Vaccines